EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Cardiovascular Implications in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review

Mithil Gowda Suresh iD, Safia Mohamed iD, Harinivaas Shanmugavel Geetha iD, Sushmita Prabhu iD, Nitin Trivedi iD, Priyal Dilip Mehta iD, Udaya Kumar Damodaran iD, Ajit Brar iD, Aalam Sohal iD, Juniali Hatwal iD, Akash Batta iD

Korean Circulation Journal · 2026 · 56 (2) · 103

DOI: 10.4070/kcj.2025.0212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Korean Circulation Journal, 2026. Verfasst von Mithil Gowda Suresh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most prevalent chronic liver disease globally and a key driver of cardiometabolic morbidity. Beyond hepatic manifestations, MASLD significantly elevates the risk of cardiovascular disease (CVD)-including myocardial infarction, ischemic stroke, heart failure, and cardiovascular mortality-through overlapping mechanisms such as visceral adiposity, insulin resistance, inflammation, oxidative stress, and dyslipidemia. Epidemiologic data demonstrate a consistent and independent association between MASLD and adverse cardiovascular outcomes. Subclinical changes in vascular structure and function precedes overt events, underscoring the need for early detection and proactive risk stratification. While glucagon-like-peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors offer dual hepatic and cardiovascular benefits, recent trials have revealed nuances in efficacy across patient populations, particularly in heart failure with preserved ejection fraction and cirrhotic cohorts. Non-invasive diagnostics-including elastography, magnetic resonance elastography, magnetic resonance imaging-derived proton density fat fraction, and machine learning-based tools-are enhancing the precision of MASLD staging and risk assessment. However, implementation remains variable, and cost-effectiveness in CVD screening is underexplored. This review synthesizes current knowledge on the MASLD-CVD interface, critically appraises existing evidence, and identifies gaps in mechanistic understanding, diagnostics, and therapeutics. We advocate for an integrated, multidisciplinary framework combining hepatology and cardiology expertise to optimize patient care in this evolving disease landscape.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular diseasesDiagnostic imagingFatty liverGlucagon-like peptide 1 receptor agonistsRisk assessment

Autor:innen und Institutionen

  • Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
  • Department of Internal Medicine, University of Massachusetts Chan Medical School-Baystate Medical Center, Springfield, MA, USA.
  • Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA.
  • Department of Gastroenterology, Creighton University School of Medicine, Phoenix, AZ, USA.
  • Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Cardiology, Dayanand Medical College and Hospital, Civil Lines, Ludhiana, Punjab, India. akashbatta02@gmail.com.

ORCID-Profile: Mithil Gowda Suresh, Safia Mohamed, Harinivaas Shanmugavel Geetha, Sushmita Prabhu, Nitin Trivedi, Priyal Dilip Mehta, Udaya Kumar Damodaran, Ajit Brar, Aalam Sohal, Juniali Hatwal, Akash Batta

Zitieren

APA

Suresh, M. G., Mohamed, S., Geetha, H. S., Prabhu, S., Trivedi, N., Mehta, P. D., Damodaran, U. K., Brar, A., Sohal, A., Hatwal, J., & Batta, A. (2026). Cardiovascular Implications in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. Korean Circulation Journal, 56(2), 103. https://doi.org/10.4070/kcj.2025.0212

Vancouver

Suresh MG, Mohamed S, Geetha HS, Prabhu S, Trivedi N, Mehta PD, et al. Cardiovascular Implications in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. Korean Circulation Journal. 2026;56(2):103. doi:10.4070/kcj.2025.0212

BibTeX
@article{Suresh2026,
  author = {Suresh, Mithil Gowda and Mohamed, Safia and Geetha, Harinivaas Shanmugavel and Prabhu, Sushmita and Trivedi, Nitin and Mehta, Priyal Dilip and Damodaran, Udaya Kumar and Brar, Ajit and Sohal, Aalam and Hatwal, Juniali and Batta, Akash},
  title = {Cardiovascular Implications in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review},
  journal = {Korean Circulation Journal},
  year = {2026},
  volume = {56},
  number = {2},
  pages = {103},
  doi = {10.4070/kcj.2025.0212}
}
Kostenlos starten →